Targeting the function of mature dendritic cells by human cytomegalovirus:: A multilayered viral defense strategy

被引:169
作者
Raftery, MJ
Schwab, M
Eibert, SM
Samstag, Y
Walczak, H
Schönrich, G
机构
[1] Humboldt Univ, Inst Virol, Charite Med Sch, D-10117 Berlin, Germany
[2] Heidelberg Univ, Inst Hyg, Dept Med Virol, D-69120 Heidelberg, Germany
[3] Heidelberg Univ, Inst Immunol, D-69120 Heidelberg, Germany
[4] Deutsch Krebsforschungszentrum, German Canc Res Ctr, Dept Apoptosis Regulat, Tumor Immunol Program, D-69120 Heidelberg, Germany
关键词
D O I
10.1016/S1074-7613(01)00239-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human cytomegalovirus (HCMV) can suppress and evade the immune system. We have identified as a mechanism the ability of HCMV to infect dendritic cells (DC), which initiate the antiviral immune response. HCMV-infected DC show enhanced expression of costimulatory molecules. In contrast, MHC molecules are partially downregulated, leading to a reduced antigen-presenting capacity. Moreover, the apoptosis-inducing ligands CD95L (FasL) and tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) are upregulated, thereby enabling HCMV-infected DC to delete activated T lymphocytes. This additional layer of viral defense is complemented by nondeletional mechanisms, which suppress surviving T cells. Thus, infection of DC allows the virus to blunt the antiviral T cell response by a multilayered defense strategy and could play a pivotal role in HCMV-triggered immuno-suppression.
引用
收藏
页码:997 / 1009
页数:13
相关论文
共 57 条
[1]   The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP [J].
Ahn, K ;
Gruhler, A ;
Galocha, B ;
Jones, TR ;
Wiertz, EJHJ ;
Ploegh, HL ;
Peterson, PA ;
Yang, Y ;
Fruh, K .
IMMUNITY, 1997, 6 (05) :613-621
[2]   Human cytomegalovirus inhibits antigen presentation by a sequential multistep process [J].
Ahn, KS ;
Angulo, A ;
Ghazal, P ;
Peterson, PA ;
Yang, Y ;
Fruh, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :10990-10995
[3]   Viral mechanisms of immune evasion [J].
Alcami, A ;
Koszinowski, UH .
IMMUNOLOGY TODAY, 2000, 21 (09) :447-455
[4]   Safety and antitumor activity of recombinant soluble Apo2 ligand [J].
Ashkenazi, A ;
Pai, RC ;
Fong, S ;
Leung, S ;
Lawrence, DA ;
Masters, SA ;
Blackie, C ;
Chang, L ;
McMurtrey, AE ;
Hebert, A ;
DeForge, L ;
Koumenis, IL ;
Lewis, D ;
Harris, L ;
Bussiere, J ;
Koeppen, H ;
Shahrokh, Z ;
Schwall, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162
[5]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[6]   Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood [J].
Bender, A ;
Sapp, M ;
Schuler, G ;
Steinman, RM ;
Bhardwaj, N .
JOURNAL OF IMMUNOLOGICAL METHODS, 1996, 196 (02) :121-135
[7]   HLA-DR-mediated apoptosis susceptibility discriminates differentiation stages of dendritic/monocytic APC [J].
Bertho, N ;
Drénou, B ;
Laupeze, B ;
Le Berre, C ;
Amiot, L ;
Grosset, JM ;
Fardel, O ;
Charron, D ;
Mooney, N ;
Fauchet, R .
JOURNAL OF IMMUNOLOGY, 2000, 164 (05) :2379-2385
[8]   Interactions of viruses with dendritic cells: A double-edged sword [J].
Bhardwaj, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (06) :795-799
[9]   INFLUENZA VIRUS-INFECTED DENDRITIC CELLS STIMULATE STRONG PROLIFERATIVE AND CYTOLYTIC RESPONSES FROM HUMAN CD8+ T-CELLS [J].
BHARDWAJ, N ;
BENDER, A ;
GONZALEZ, N ;
BUI, LK ;
GARRETT, MC ;
STEINMAN, RM .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (02) :797-807
[10]   SMALL AMOUNTS OF SUPERANTIGEN, WHEN PRESENTED ON DENDRITIC CELLS, ARE SUFFICIENT TO INITIATE T-CELL RESPONSES [J].
BHARDWAJ, N ;
YOUNG, JW ;
NISANIAN, AJ ;
BAGGERS, J ;
STEINMAN, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) :633-642